A financial report on a publicly traded company with Capital Region operations, drawn from Securities and Exchange Commission filings.
Nasdaq: REGN Headquarters: 777 Old Saw Mill River Road, Tarrytown; manufacturing plant at 81 Columbia Turnpike, East Greenbush Company founded: 1988 Activities: Develops -- and intends to commercialize -- products for the treatment of serious medical conditions including cancer, diseases of the eye, rheumatoid arthritis, allergies, asthma and obesity. Employees: 709, including 275 in East Greenbush Performance: Regeneron's stock outperformed both the Nasdaq Pharmaceutical Stocks Index and the Nasdaq Stock Market Index over a five-year period ending Dec. 31. A $100 investment in Regeneron on Dec. 31, 1998, rose to $200 by year-end 2003. The same investment in the pharmaceuticals index increased to $190 but fell to $92 …
Комментариев нет:
Отправить комментарий